Loading clinical trials...
Loading clinical trials...
Identification of Myocardial Ischemia With Magnetocardiography Using Single Photon Emission Computed Tomography (SPECT) as a Reference Standard
This is a prospective clinical study aiming to investigate the efficacy of Magnetocardiography (MCG) in detecting myocardial ischemia in patients of a suspected non-ST-elevation-acute coronary syndrome (NSTE-ACS) by using Single photon emission computed tomography (SPECT) as the gold standard for determining the presence and severity of myocardial ischemia.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Qilu Hospital of Shandong University
Jinan, Shandong, China
Start Date
February 12, 2024
Primary Completion Date
October 31, 2024
Completion Date
December 31, 2024
Last Updated
August 21, 2024
228
ESTIMATED participants
Magnetocardiography
DEVICE
Single photon emission computed tomography (SPECT)
DEVICE
Lead Sponsor
Qilu Hospital of Shandong University
Collaborators
NCT04992572
NCT07477002
NCT07474935
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions